SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-134773
Filing Date
2024-05-09
Accepted
2024-05-09 07:43:00
Documents
15
Period of Report
2024-05-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d835189d8k.htm   iXBRL 8-K 40431
2 EX-99.1 d835189dex991.htm EX-99.1 16272
6 GRAPHIC g835189g0508032057983.jpg GRAPHIC 4501
  Complete submission text file 0001193125-24-134773.txt   197608

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mack-20240508.xsd EX-101.SCH 2829
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20240508_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20240508_pre.xml EX-101.PRE 11247
19 EXTRACTED XBRL INSTANCE DOCUMENT d835189d8k_htm.xml XML 3685
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 24928617
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)